Related references
Note: Only part of the references are listed.Relationship Between Clinical and Pathologic Features of Ductal Carcinoma In Situ and Patient Age An Analysis of 657 Patients
Laura C. Collins et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2009)
Estrogen receptor status in CHEK2-positive breast cancers: implications for chemoprevention
C. Cybulski et al.
CLINICAL GENETICS (2009)
Clinical classification of BRCA1 and BRCA2 DNA sequence variants:: The value of cytokeratin profiles and evolutionary analysis -: A report from the kConFab investigators
Amanda B. Spurdle et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Molecular profiling pleomorphic lobular carcinomas of the breast: evidence for a common molecular genetic pathway with classic lobular carcinomas
P. T. Simpson et al.
JOURNAL OF PATHOLOGY (2008)
The emerging landscape of breast cancer susceptibility
Michael R. Stratton et al.
NATURE GENETICS (2008)
Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families
Emiliano Honrado et al.
MODERN PATHOLOGY (2007)
Predominance of the basal type and HER-2/neu type in brain metastasis from breast cancer
Jochen Gaedcke et al.
MODERN PATHOLOGY (2007)
Genome-wide association study identifies novel breast cancer susceptibility loci
Douglas F. Easton et al.
NATURE (2007)
Cancer genes associated with phenotypes in monoallelic and biallelic mutation carriers: new lessons from old players
Nazneen Rahman et al.
HUMAN MOLECULAR GENETICS (2007)
BRCA1 dysfunction in sporadic basal-like breast cancer
N. C. Turner et al.
ONCOGENE (2007)
PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene
Nazneen Rahman et al.
NATURE GENETICS (2007)
BRCA2 mutation-associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays
Anita L. Bane et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2007)
Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival
Laura G. Fulford et al.
BREAST CANCER RESEARCH (2007)
Histopathological features of breast cancer in carriers of ATM gene variants
R. L. Balleine et al.
HISTOPATHOLOGY (2006)
Morphology of breast cancer as a means of triage of patients for BRCA1 genetic testing
Gelareh Farshid et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2006)
Pathology and gene expression of hereditary breast tumors associated with BRCA1, BRCA2 and CHEK2 gene mutations
E. Honrado et al.
ONCOGENE (2006)
The CHEK2 gene and inherited breast cancer susceptibility
H. Nevanlinna et al.
ONCOGENE (2006)
Caveolin-1 expression is associated with a basal-like phenotype in sporadic and hereditary breast cancer
Socorro Maria Rodriguez Pinilla et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Spectrum of mutations in BRCA1, BRCA2, CHEK2, and TP53 in families at high risk of breast cancer
T Walsh et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Optimal selection of individuals for BRCA mutation testing:: A comparison of available methods
PA James et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants
PK Lovelock et al.
JOURNAL OF MEDICAL GENETICS (2006)
Spectrum of breast cancer metastasis in BRCA1 mutation carriers:: highly increased incidence of brain metastases
L Albiges et al.
ANNALS OF ONCOLOGY (2005)
Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-associated tumors
E Honrado et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
The molecular pathology of hereditary breast cancer:: genetic testing and therapeutic implications
E Honrado et al.
MODERN PATHOLOGY (2005)
Targeting the DNA repair defect of BRCA tumours
N Turner et al.
CURRENT OPINION IN PHARMACOLOGY (2005)
Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype
SR Lakhani et al.
CLINICAL CANCER RESEARCH (2005)
Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer
JB Arnes et al.
CLINICAL CANCER RESEARCH (2005)
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
HE Bryant et al.
NATURE (2005)
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
H Farmer et al.
NATURE (2005)
Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers
J Palacios et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
The prognostic implication of the basal-like (cyclin Ehigh/p27low/p53+/glomeruloid-microvascular-proliferation+) phenotype of BRCA1-related breast cancer
WD Foulkes et al.
CANCER RESEARCH (2004)
ATM and ataxia telangiectasia - Second in Molecular Medicine Review Series
PJ McKinnon
EMBO REPORTS (2004)
Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer
WD Foulkes et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
HER-2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry
LA Quenneville et al.
CANCER (2002)
The pathology of familial breast cancer:: Predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2
SR Lakhani et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Cancer susceptibility and the functions of BRCA1 and BRCA2
AR Venkitaraman
CELL (2002)
Absence of CCND 1 gene amplification in breast tumours of BRCA1 mutation carriers
SAJ Vaziri et al.
JOURNAL OF CLINICAL PATHOLOGY-MOLECULAR PATHOLOGY (2001)
Low expression of bcl-2 in Brca1-associated breast cancers
P Freneaux et al.
BRITISH JOURNAL OF CANCER (2000)